Client News
Filter by:
- Nov 2 2021 OncoSec Medical Hosting SITC Key Opinion Leader Webinar on Updated Data from the KEYNOTE-695 Study
- Nov 1 2021 Arch Therapeutics Presents AC5® Advanced Wound System During Innovation Spotlight at 2021 Symposium on Advanced Wound Care (SAWC)
- Oct 20 2021 OncoSec Provides Business Update
- Sep 21 2021 AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today
- Sep 14 2021 AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma
- Sep 13 2021 AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications
- Sep 10 2021 AzurRx BioPharma Announces Reverse Stock Split
- Sep 10 2021 AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
- Aug 16 2021 OncoSec Provides Leadership Update
- Jul 26 2021 OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference